The Venture Codex Logo

The Venture Codex

Bayer

Kaiser-Wilhelm-Allee 1, Leverkusen, Nordrhein-Westfalen, 51373, Germany

Overview

Life science company focused on healthcare and nutrition solutions.

Founded

1863

Deals · 12mo

0

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series A
Series C

Geographic focus

Canada
China
Sweden
United Kingdom
...

Sector focus

Biotechnology
Chemical
Health Care
Life Science
...

Investment portfolio

10rounds
NAMEDATESIZE
Decibel Bio
Mar 2025Participated
$12 MOther Equity
Acorai
Jan 2024Participated
$5 MSeed
Jixing Pharmaceuticals
Jan 2024Led
$162 MOther Equity
OneDrop
Aug 2020Led
$35 MSeries C
ONE DROP
Aug 2020Led
$35 MSeries C
Huma
Nov 2019Led
$25 MSeries B
Pyxis Oncology
Jul 2019Led
$22 MSeries A
New Company
Sep 2017Participated
$100 MSeries A
Boragen
Mar 2017Participated
$10 MSeries A
BlueRock Therapeutics
Dec 2016Participated
$225 MSeries A
Decibel Bio
Mar 2025Participated
$12 MOther Equity
Acorai
Jan 2024Participated
$5 MSeed
Jixing Pharmaceuticals
Jan 2024Led
$162 MOther Equity
OneDrop
Aug 2020Led
$35 MSeries C
ONE DROP
Aug 2020Led
$35 MSeries C
Huma
Nov 2019Led
$25 MSeries B
Pyxis Oncology
Jul 2019Led
$22 MSeries A
New Company
Sep 2017Participated
$100 MSeries A
Boragen
Mar 2017Participated
$10 MSeries A
BlueRock Therapeutics
Dec 2016Participated
$225 MSeries A
10
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Bayer: 10 funding rounds are recorded in the selected participation categories.All available history.
Bayer: 10 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed01
Series A13
Series B10
Series C+20
Other Equity11

Monthly Deal Activity

Bayer: 10 deals are recorded across 119 months.All available history.
Bayer: 10 deals are recorded across 119 months. All available history
MonthDeals
Dec '161
Jan '170
Feb '170
Mar '171
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '171
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '191
Aug '190
Sep '190
Oct '190
Nov '191
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '202
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '242
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '251
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Bayer: Health & Life Sciences is the largest displayed sector by deal count (9 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Bayer: Health & Life Sciences is the largest displayed sector by deal count (9 deals). All available history
SectorDeals
Health & Life Sciences9
Food & Agriculture3
Space & Frontier Tech3
Enterprise Software2
Government & Defense1
Manufacturing1
AI & Machine Learning1

Deal Size Distribution

Bayer: 10 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Bayer: 10 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M0
$10M-$25M3
$25M-$50M3
$50M-$100M0
$100M-$250M3
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Bayer: United States has the largest recorded deal count among the displayed regions (5 deals).All available history.

Top 5 of 5 regions; European countries are grouped as Europe.

Bayer: United States has the largest recorded deal count among the displayed regions (5 deals). All available history
RegionDeals
United States5
Europe2
440941
Canada1
China1
Bayer: 20 co-investors are shown, with Agent Capital sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Bayer: 20 co-investors are shown, with Agent Capital sharing 1 recorded deals. All available history
Co-investorShared deals
Agent Capital1
AgTech Accelerator1
Alexandria Venture Investments1
ARCH Venture Partners1
Bill & Melinda Gates Foundation1
Breakthrough Energy Ventures1
Carma Fund1
Cedars-Sinai1
Elanco Animal Health1
Flagship Pioneering1
Future Ventures1
Ginkgo Bioworks1
Hatteras Venture Partners1
Healthbox1
Ipsen1
Longwood Fund1
Mayo Clinic1
Meridian Health Ventures (KHP Ventures)1
Mountain Group Partners1
NWS Holdings1

Investment Strategy

Bayer: Led accounts for 50% and participating for 50% of round participation.All available history.
Bayer: Led accounts for 50% and participating for 50% of round participation. All available history
CategoryDeals (count)Share (%)
Led550%
Participating550%
Bayer: Single-lead accounts for 80% and co-led for 20% of lead dynamics.All available history.
Bayer: Single-lead accounts for 80% and co-led for 20% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead480%
Co-led120%

Team

Andrew Chapple

Crop Science Division, representing SETAC DRAW

Daniel Paulson

Vice President Global Clinical Development

Heike Prinz

Head Of Commercial Operations EMEA, Member of the Pharmaceuticals Executive Committee

Juergen Eckhardt

Head at Bayer Venture Investments

Jun Tang

Head of Brand Management

Kimberly Harrington

VP, Head of Digital Engineering

Nuno Fontes

SVP, Head of Global Biologics Development

Tiffany McLaud

GM of Pain / Cardio / Skin Health / Consumer Health Accelerator